Dr. Okada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1450 3rd Street
San Francisco, CA 94158Phone+1 415-476-1637
Education & Training
- Nagoya University - School of MedicineClass of 1991
Certifications & Licensure
- PA State Medical License 2004 - 2014
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Clinical Trials
- H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas Start of enrollment: 2016 Nov 18
Publications & Presentations
PubMed
- 2 citationsProgramming tissue-sensing T cells that deliver therapies to the brain.Milos S Simic, Payal B Watchmaker, Sasha Gupta, Yuan Wang, Sharon A Sagan
Science. 2024-12-06 - Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine gliobla...Megan Montoya, Sara A Collins, Pavlina Chuntova, Trishna S Patel, Takahide Nejo
Neuro-Oncology. 2024-12-05 - Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology: A Review.Fatme Seval Ismail, Marco Gallus, Sven G Meuth, Hideho Okada, Hans-Peter Hartung
JAMA Neurology. 2024-11-25
Journal Articles
- Immunotherapy of Primary Brain Tumors: Facts and HopesHideho Okada, MD, Clinical Cancer Research
- Single-Cell Profiling of Human Gliomas Reveals Macrophage Ontogeny as a Basis for Regional Differences in Macrophage Activation in the Tumor MicroenvironmentDaniel A Lim, S John Liu, Manish Aghi, Hideho Okada, Nduka M Amankulor, Arnold R Kriegstein, BioMed Central
Press Mentions
- Killer T Cells Programmed for Tissue- and Tumor-Specific TargetingDecember 6th, 2024
- Molecular Zip Code Draws Killer T Cells to Brain TumorsDecember 5th, 2024
- Next-Generation T-cell Therapeutics Set Sights on Cancers, Autoimmune Disorders and MoreJune 17th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: